BackFresh Tracks Therapeutics Overview

Fresh Tracks Therapeutics Research & Development

Research & Development expenses for FRTX.

Quarterly R&D Expenses

$10000.00
↓ 99.62% YoY

As of Dec 31, 2023

Annual R&D Expenses (TTM)

$3.18M
↓ 77.34% YoY

Trailing 12 months ending Dec 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin